These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography. Aoyama R; Takano H; Kobayashi Y; Kitamura M; Asai K; Amano Y; Kumita SI; Shimizu W PLoS One; 2017; 12(11):e0188479. PubMed ID: 29176885 [TBL] [Abstract][Full Text] [Related]
10. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. Grover-McKay M; Schwaiger M; Krivokapich J; Perloff JK; Phelps ME; Schelbert HR J Am Coll Cardiol; 1989 Feb; 13(2):317-24. PubMed ID: 2783595 [TBL] [Abstract][Full Text] [Related]
11. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280 [TBL] [Abstract][Full Text] [Related]
12. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529 [TBL] [Abstract][Full Text] [Related]
13. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition. Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154 [TBL] [Abstract][Full Text] [Related]
14. Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy. Perrone-Filardi P; Bacharach SL; Dilsizian V; Panza JA; Maurea S; Bonow RO Am J Cardiol; 1993 Jul; 72(2):199-204. PubMed ID: 8328384 [TBL] [Abstract][Full Text] [Related]
15. Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathy. Katagiri M; Nakahara T; Murata M; Ogata Y; Matsusaka Y; Iwabuchi Y; Yamada Y; Fukuda K; Jinzaki M Ann Nucl Med; 2017 Jun; 31(5):399-406. PubMed ID: 28364376 [TBL] [Abstract][Full Text] [Related]
16. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416 [TBL] [Abstract][Full Text] [Related]
17. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935 [TBL] [Abstract][Full Text] [Related]
18. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981 [TBL] [Abstract][Full Text] [Related]
19. Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance. Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Ueda T; Temma S; Yonekura Y; Yamashita K; Konishi J; Mikawa H Am J Cardiol; 1991 Dec; 68(17):1638-45. PubMed ID: 1746466 [TBL] [Abstract][Full Text] [Related]